GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

115 hedge funds and large institutions have $1.39B invested in G1 Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+20
Holders Change %
+21.05%
% of All Funds
2.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
32
Increased
47
Reduced
21
Closed
12
Calls
$5K
Puts
$675K
Net Calls
-$670K
Net Calls Change
-$670K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$89.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$102M
3
Wellington Management Group
Wellington Management Group
Massachusetts
$168M
4
Fidelity Investments
Fidelity Investments
Massachusetts
$273M
5
Capital International Investors
Capital International Investors
California
$13.9M

Top Sellers

1
State Street
State Street
Massachusetts
$42.9M
2
Franklin Resources
Franklin Resources
California
$60.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
4
VOYA Investment Management
VOYA Investment Management
Georgia
$18.5M
5
CAM
Cormorant Asset Management
Massachusetts
$33.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
TAM
126
Tyers Asset Management
Texas
– -$11K -242 Closed
GHCM
127
Glen Harbor Capital Management
California
– -$8K -176 Closed
PCM
128
Prelude Capital Management
New York
– -$6K -139 Closed
2 3 4 5
6